Print

Singulex, Inc. Secures $55 Million in Debt and Equity Financing  
9/26/2013 9:47:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., the leading provider of Single Molecule Counting (SMC™) technology for scientific discovery and clinical testing services, today announced it has secured a debt facility for up to $40 million from Oxford Finance and Silicon Valley Bank. In June 2013, the Company also raised $15 million in equity financing. The Company will use the funding to advance the development and commercialization of a global in vitro diagnostics business based on Singulex’s SMC technology.

Help employers find you! Check out all the jobs and post your resume.

//-->